NSCI Stock Overview
Engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Nanalysis Scientific Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.45 |
| 52 Week High | CA$0.66 |
| 52 Week Low | CA$0.34 |
| Beta | 0.76 |
| 1 Month Change | 7.23% |
| 3 Month Change | -9.18% |
| 1 Year Change | -23.28% |
| 3 Year Change | -28.23% |
| 5 Year Change | n/a |
| Change since IPO | -19.09% |
Recent News & Updates
Recent updates
Nanalysis Scientific Corp. (CVE:NSCI) Stock Catapults 29% Though Its Price And Business Still Lag The Industry
May 12
Benign Growth For Nanalysis Scientific Corp. (CVE:NSCI) Underpins Stock's 25% Plummet
Mar 24Nanalysis Scientific Corp. (CVE:NSCI) Shares Fly 43% But Investors Aren't Buying For Growth
Feb 08We Think Nanalysis Scientific (CVE:NSCI) Has A Fair Chunk Of Debt
Jan 31Would Nanalysis Scientific (CVE:NSCI) Be Better Off With Less Debt?
Aug 26Nanalysis Scientific Corp.'s (CVE:NSCI) Price Is Right But Growth Is Lacking
Apr 17Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?
Dec 08Is Nanalysis Scientific (CVE:NSCI) Weighed On By Its Debt Load?
Jul 15Health Check: How Prudently Does Nanalysis Scientific (CVE:NSCI) Use Debt?
Jan 24Is Nanalysis Scientific (CVE:NSCI) Using Debt Sensibly?
Mar 29Nanalysis Scientific (CVE:NSCI) Has Debt But No Earnings; Should You Worry?
Dec 14
Shareholder Returns
| NSCI | CA Medical Equipment | CA Market | |
|---|---|---|---|
| 7D | 1.1% | -3.0% | -1.9% |
| 1Y | -23.3% | -30.7% | 12.2% |
Return vs Industry: NSCI exceeded the Canadian Medical Equipment industry which returned -30.7% over the past year.
Return vs Market: NSCI underperformed the Canadian Market which returned 12.2% over the past year.
Price Volatility
| NSCI volatility | |
|---|---|
| NSCI Average Weekly Movement | 10.6% |
| Medical Equipment Industry Average Movement | 10.6% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CA Market | 17.4% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: NSCI has not had significant price volatility in the past 3 months.
Volatility Over Time: NSCI's weekly volatility (11%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 249 | Sean Krakiwsky | www.nanalysis.com |
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K’Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.
Nanalysis Scientific Corp. Fundamentals Summary
| NSCI fundamental statistics | |
|---|---|
| Market cap | CA$49.73m |
| Earnings (TTM) | -CA$16.20m |
| Revenue (TTM) | CA$28.47m |
1.8x
P/S Ratio-3.1x
P/E RatioIs NSCI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NSCI income statement (TTM) | |
|---|---|
| Revenue | CA$28.47m |
| Cost of Revenue | CA$24.50m |
| Gross Profit | CA$3.97m |
| Other Expenses | CA$20.17m |
| Earnings | -CA$16.20m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.14 |
| Gross Margin | 13.95% |
| Net Profit Margin | -56.90% |
| Debt/Equity Ratio | 81.1% |
How did NSCI perform over the long term?
See historical performance and comparison